Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Suzhou Fengbei Biotech Stock Co's total inventories for the quarter that ended in Mar. 2026 was ¥454 Mil. Suzhou Fengbei Biotech Stock Co's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was ¥488 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Suzhou Fengbei Biotech Stock Co's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was ¥4.89.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Suzhou Fengbei Biotech Stock Co's Days Inventory for the
three
months ended in Mar. 2026 was 42.75.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Suzhou Fengbei Biotech Stock Co's Inventory Turnover for the quarter that ended in Mar. 2026 was 2.13.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Suzhou Fengbei Biotech Stock Co's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.44.
Suzhou Fengbei Biotech Stock Co (SHSE:603334) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Suzhou Fengbei Biotech Stock Co's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Suzhou Fengbei Biotech Stock Co's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Suzhou Fengbei Biotech Stock Co Total Inventories Related Terms
Suzhou Fengbei Biotech Stock Co Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzhou Fengbei Biotech Stock Co Total Inventories Chart
Suzhou Fengbei Biotech Stock Co Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a Total Inventories of ¥454 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Suzhou Fengbei Biotech Stock Co and its competitors.
Is Suzhou Fengbei Biotech Stock Co's Total Inventories too high?
Suzhou Fengbei Biotech Stock Co's current Total Inventories is ¥454 Mil. Overall, Suzhou Fengbei Biotech Stock Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Suzhou Fengbei Biotech Stock Co's Total Inventories compare to WM and RSG?
Suzhou Fengbei Biotech Stock Co's Total Inventories of ¥454 Mil can be compared against companies in the Waste Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Waste Management company?
A good Total Inventories depends on the Waste Management industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Suzhou Fengbei Biotech Stock Co and its competitors. Suzhou Fengbei Biotech Stock Co's current Total Inventories is ¥454 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Fengbei Biotech Stock Co stock overvalued right now?
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a current Total Inventories of ¥454 Mil. The current Total Inventories is ¥454 Mil. Suzhou Fengbei Biotech Stock Co's overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Suzhou Fengbei Biotech Stock Co (SHSE:603334), the current Total Inventories is ¥454 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Suzhou Fengbei Biotech Stock Co Business Description
Suzhou Fengbei Biotech Stock Co Ltd is focused on the comprehensive utilization of waste oil and fat resources. The company is engaged in the research and development, production, and sales of industrial packaging materials, methyl oleate, and methylated soybean oil (excluding food products). It operates as an independent import and export agent for various commodities and technologies. The company's licensed projects include Fertilizer production, and General projects include Technical services, technical development, technical consultation, technical exchange, technology transfer, and technology promotion. It is into the research and development of bio-organic fertilizers, compound microbial fertilizers, and bio-pesticide technology.
40GF Score
Get the complete analysis for SHSE:603334
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603334 has been successfully added to your 
